PharmaBoardroom

Is Everything So Wrong at GSK?

British pharmaceuticals giant, GSK, one of the UK’s largest companies by market capitalization, is once again finding itself under the spotlight as…

China Strives for First-In-Class Drug Innovation with New Patent…

In a comprehensive new piece, European Patent Attorney André Bourgouin and Adjunct Professor at CEIBS Eric Bouteiller examine the potential impact of…

Italy’s Market Access Reform: A Watershed Moment?

In recent months, a profound transformation has been occurring right at the core of the Italian pharmaceutical industry as the most significant…

Note to Biogen: Your Marketing is Showing

In his latest PharmaBoardroom piece, John Singer looks at Biogen’s marketing campaign for its new Alzheimer’s drug, extending and linking the…

Jakob Skaarup Nielsen – CEO, Healthcare DENMARK

Healthcare DENMARK is a non-profit organization and public-private partnership representing Danish healthcare stakeholders internationally. Jakob…

Cindy Engelbart – Director Life Science APAC, Agility

Cindy Engelbart, director of mid-sized logistics player Agility's life science operations in APAC, highlights some of the key trends in global…

Vincent Forster – CEO, Versantis

Dr Vincent Forster of Versantis, a Swiss biotech aiming to develop a new generation of liver disease therapeutics and diagnostics, introduces the…

Takafumi Horii – SVP, Head of Japan Oncology Business Unit,…

Experienced global leader Takafumi Horii explains the rationale behind returning to his home nation of Japan to head up Takeda’s Japan Oncology…

Trad Alkhelaiwi – Country Director, Amgen Saudi Limited

Trad Alkhelaiwi, country director for Amgen in Saudi Arabia, discusses the intricacies of the Saudi healthcare transformation including the push for a…